ABSTRACT: To reduce the production of wear particles and subsequent aseptic loosening, we created a human articular cartilagemimicked surface for a highly cross-linked polyethylene liner, whose surface grafted layer consisted of a biocompatible phospholipid polymer, poly(2-methacryloyloxyethyl phosphorylcholine). Although our previous in vitro findings showed that poly(2-methacryloyloxyethyl phosphorylcholine)-grafted particles were biologically inert and caused no subsequent bone resorptive responses, and poly(2-methacryloyloxyethyl phosphorylcholine) grafting markedly decreased wear in hip joint simulator tests, the clinical safety, and in vivo wear resistance of poly(2-methacryloyloxyethyl phosphorylcholine)-grafted highly cross-linked polyethylene liners remained open to question. Therefore, in the present study, we evaluated clinical and radiographic outcomes of poly(2-methacryloyloxyethyl phosphorylcholine)-grafted highly cross-linked polyethylene liners 5 years subsequent to total hip replacement in 68 consecutive patients. No reoperation was required for any reason, and no adverse events were associated with the implanted liners. The average Harris Hip Score increased from 38.6 preoperatively to 96.5 5 years postoperatively, and health-related quality of life, as indicated by the Short Form 36 Health Survey, improved. Radiographic analyses showed no periprosthetic osteolysis or implant migration. Between 1 and 5 years postoperatively, the mean steady-state wear rate was 0.002 mm/year, which represented a marked reduction relative to other highly cross-linked polyethylene liners, and appeared to be unaffected by patient-related or surgical factors. Although longer follow up is required, poly(2-methacryloyloxyethyl phosphorylcholine)-grafted highly cross-linked polyethylene liners improved midterm clinical outcomes. The clinical safety and wear-resistance results are encouraging with respect to the improvement of long-term clinical outcomes with poly(2-methacryloyloxyethyl phosphorylcholine)-grafted highly cross-linked polyethylene liners. ß
Total hip replacement (THR) is one of the most successful and cost-effective surgical options available to relieve pain and restore hip joint function in patients with debilitating hip diseases such as osteoarthritis and osteonecrosis. More than one million arthroplasties are performed annually worldwide, and recent surveys revealed that this number is increasing rapidly because of the expansion of the elderly population, in whom life expectancy and activity levels have increased.
1,2 Therefore, increasing the longevity of artificial hip joints to avoid revision surgery is important. One of the reasons for revision surgery is aseptic loosening resulting from periprosthetic osteolysis. 3, 4 Pathogenesis of periprosthetic osteolysis is a wellknown consequence of inflammatory response in the host and initiated by foreign-body reaction in macrophages to ultrahigh molecular weight polyethylene (PE) wear particles originating mainly from the articulating surfaces of artificial hip joints. 5 The macrophage phagocytosis of PE particles is followed by secretion of prostaglandin E 2 and cytokines, resulting in osteoclastogenesis and bone resorption. Therefore, decreases in the production of wear particles and bone resorptive responses may lead to the prevention of periprosthetic osteolysis and prolong the longevity of artificial hip joints.
Highly cross-linked polyethylene (HXLPE), the "first-generation HXLPE," was introduced in the late 1990s to decrease periprosthetic osteolysis related to PE wear particles. 6 Following its introduction, positive clinical findings regarding wear resistance of HXLPE were reported at medium-term follow-up times. 10 years later. Among them, the Australian Orthopaedic Association National Joint Replacement Registry reported a revision rate of 5.2% of HXLPE (N ¼ 152,076) during the preceding 14 years, with loosening/osteolysis being the second cause of revision surgery (21.2%). 14 Lachiewicz et al. reported radiological results of HXLPE at a mean follow-up of 11 years (range, 10-14 years) and osteolytic lesions were noted in 12 hips (14%). 15 They also reported that there were no osteolytic lesions in the same cohorts during the 5-8 years follow-up. 12 Although "first-generation HXLPE" decreased the wear and osteolysis at medium-term follow-up times, Kurtz et al. suggested that "first-generation HXLPE" was clinically introduced at a time when 28-mm femoral heads were used, whereas today there is a demand for larger diameter articulations for THR with head diameters of up to 44 mm. 16 Although larger femoral heads improve the stability of articulating surfaces, they have an increased sliding distance and velocity per step between bearing surfaces of the THA, which results in an increased wear rate compared with smaller femoral heads. 17 Moreover, a larger femoral head requires a thinner PE liner for retaining the acetabular bone, which can possibly accelerate wear and/or fracture of the liner. 18 Therefore, these changes to femoral head diameter in combination with "first-generation HXLPE" use may increase the production of wear particles, thereby consequently resulting in osteoclastogenesis, bone resorption, and periprosthetic osteolysis. 5 In addition, as in osteoclastogenesis, the volume of wear as well as the shape and diameter of the particle is important. Although the wear volume with HXLPE use has been shown in vitro to be less than that with conventional PE, some studies have suggested that it generates smaller particles that are more biologically active in stimulating osteolysis in vitro, whereas recent evidence suggests fewer small particles are generated with HXLPE. 19, 20 Hence, the clinical need to increase the lifespan of THA to 20 to 30 years have led to the development of additional "second-generation HXLPE" so as to reduce wearing using a method other than irradiation. [21] [22] [23] To reduce the production of wear particles and improve wear resistance, it is important to understand the tribology of the natural synovial joints and the role of lubrication. Although the most popular bearing couple of the artificial hip joint is composed of HXLPE acetabular liner and a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or ceramic femoral head, the friction coefficient for the bearing surface is higher than that of human articular cartilage. This difference may be caused by hydrophobicity of the HXLPE surface. 24 Fluid film lubrication via the hydrated layer at the uppermost superficial articular cartilage is an essential mode of smooth joint motion, and a nanometerscaled phospholipid layer that covers the joint cartilage surface provides hydrophilicity and serves as an effective boundary lubricant. 25 Therefore, the phospholipid-like layer on the acetabular liner surface may mimic the surface conditions of healthy articular cartilage.
To create an articular cartilage-mimicked surface for a HXLPE liner, we developed a method of surface grafting (100-200 nm in thickness) for our original hydrophilic phospholipid polymer, poly(2-methacryloyloxyethyl phosphorylcholine [MPC]) (PMPC). 26 The PMPC is a biocompatible and hydrophilic polymer, because phosphorylcholine groups in the side chain resemble biomembranes. 27 Because MPC polymers possess good biocompatibility, high lubricity, low friction, antiprotein adsorption, and a cell membrane-like surface, 26, 27 they have been used on the surfaces of several medical devices such as guide wires, intravascular stents, contact lenses, artificial lungs, and artificial hearts. 28, 29 These implants were introduced into clinical practice in 1997 under the authorization of the Food and Drug Administration in the United States and the Ministry of Health, Labour, and Welfare in Japan. Since then, no adverse reactions to MPC polymers have been reported. Therefore, the efficacy and safety of the MPC polymer are well established. Our recent study examining the biological effects of PMPC revealed that PMPC-grafted particles suppressed bone resorptive responses in a murine osteolysis model. 26 In addition, PMPC grafting on the HXLPE surface decreased friction torque by 80-90% compared with the untreated HXLPE surface and increased lubrication to levels that resembled articular cartilage under physiological conditions, without affecting the physical or mechanical properties of the HXLPE substrate. [30] [31] [32] Our previous hip simulator study revealed that PMPC grafting markedly reduced HXLPE liner wear and lowered the total number and volume of wear particles by 99.9% during 20 million loading cycles compared with untreated HXLPE liners. We extended the simulator test for a single liner to 70 million cycles and confirmed that the PMPC layer was maintained subsequent to the test. 33 In addition, we confirmed that improvement due to PMPC grafting surpassed that attributable to liner cross-linking alone or changes in femoral head material or diameter. 26, 31, 34 Although these findings suggest that the PMPCgrafted HXLPE liner may be a promising approach to extending the longevity of artificial hip joints, in vitro findings do not always translate to clinical success. 35 Therefore, we conducted a follow-up study of a prospective cohort of 80 patients who had undergone primary cementless THR with a PMPC-grafted HXLPE liner 5 years previously; we evaluated (i) clinical performance and safety and (ii) the twodimensional wear rate and correlations between wear rate and material, patient-related, and surgical factors. The outline of this study was disclosed as UMIN000003681. 
MATERIALS AND METHODS

Level of Evidence
Level III. Retrospective cohort study
Patients
We recruited a prospective consecutive series of 80 patients, who had undergone primary THR for a Charnley Class A or B, painful, noninfectious hip disorder, from five participating hospitals between April 2007 and September 2008. The study was approved by the institutional review boards of the participating hospitals, and all patients provided informed consent. The exclusion criteria were as follows: Preexisting infection, significant comorbidities, and a previous jointpreserving procedure involving the affected hip joint.
Implants and Operative Procedure
The surgery was performed by 10 surgeons from five institutions, using the posterior approach. The acetabular components included a low-profile, porous-coated, vanadiumfree titanium alloy cup with four peripheral fins (K-MAX 1 Q5LP; KYOCERA Medical Corp., Osaka, Japan) and a PMPC-grafted HXLPE liner. The size distributions of the acetabular component and liner thickness are summarized in Table 1 . Components that were 50 mm in size were used for 60 patients (60 hips; 88.2%). The mean and most common liner thicknesses were 7.8 and 6.7 mm (38.2%), respectively. In Asian populations, small acetabulum size limits acetabular component size and liner thickness. Therefore, in the present study, acetabular components were several sizes smaller and liners were thinner relative to those used in Western populations. 36, 37 All HXLPE liners were manufactured from compression-molded PE sheet stock (GUR 1020 resin) and treated with a total dose of 75 kGy gamma-ray irradiation (50 kGy for cross-linking, and 25 kGy for sterilization). At the surface of the HXLPE liner, PMPC grafting was performed using a photoinduced polymerization technique, as previously reported. [9] [10] [11] [12] The femoral component was a collarless, vanadium-free titanium alloy femoral stem (K-MAX 1 HS-6; KYOCERA Medical Corp.). The proximal press-fit area of the femoral stem was a pure titanium porous surface, bottom coated with apatite-wollastonite glass ceramic. A 26-mm diameter Co-Cr-Mo head (K-MAX 1 HH-02; KYOCERA Medical Corp.) was used in all cases. Each patient underwent the routine thromboprophylaxis regimen and postoperative rehabilitation program provided by the institution at which he or she was treated.
Clinical Evaluation
Postoperative follow up was conducted at 3 months, 6 months, 1, 3, and 5 years. Orthopedic surgeons, other than those who performed the index surgery, followed the patients preoperatively and postoperatively at each institution. During the course of the study, all suspected correlations between adverse events and the implanted PMPC-grafted HXLPE liner were recorded. Clinical performance was evaluated preoperatively and at routine follow up, using scores obtained via the evaluation chart for hip joint function authorized by the Japanese Orthopaedic Association (JOA score). 38 The JOA score consists of four categories: Pain (40 points), range of motion (20 points), gait (20 points), and activities of daily living (20 points). The sum of the points for these four categories can be used as an approximate estimate of hip function; 100 points is a perfect score and considered normal. Fujisawa et al. reported a strong correlation between JOA scores and Harris Hip Scores (r ¼ 0.843). 39 Therefore, we calculated equivalent Harris Hip Scores using the following regression formula: Harris Hip Score ¼ JOA score Â 0.979 þ 4.363.
Assessment of Quality of Life
Prior to the operation and 5 years postoperatively, patients were asked to complete the 36-Item Short Form Health Survey (SF-36), which measures patient health and consists of eight scaled scores including physical function, role limitation due to physical problems, role limitation due to emotional problems, social function, bodily pain, vitality, mental health, and perceptions of general health. 40 SF-36 data were scored using the SF-36 Health Outcomes Scoring Software Version 3.0 (QualityMetric Incorporated, Lincoln, RI). This software package generates output for all eight subscales in addition to physical (PCS), mental (MCS), and role/social component summary (RCS) scores. SF-36 scores range from 0 to 100, with a higher score indicating better health status. In addition, normalized values can be estimated to provide a reference value for the general population. 41 Each SF-36 component score was standardized using means and standard deviations (SDs) obtained from a Japanese population aged between 20 and 79 years, then transformed to normbased (mean ¼ 50, SD ¼ 10) scoring, as suggested by the survey developers.
Radiographic Evaluation
Anteroposterior (AP) non-weight-bearing pelvic and femoral digital radiographs were taken immediately subsequent to the operation and 3 weeks, 6 months, and 1, 3, and 5 years postoperatively. The distance between the X-ray tube and imaging plate was set to 100 cm, and the center of the X-ray beam was directed at the cranial end of the pubic symphysis. The digitized image data were stored at a resolution of 0.13-0.20 mm/pixel. To evaluate the acetabular component position, the acetabular component inclination angle was measured as the angle between a horizontal line connecting the ischial spines and a line tangential to the opening of the component. 42 In addition, acetabular component anteversion was measured using the trigonometric mathematics method described by Liaw et al. 43 To detect periprosthetic osteolysis and assess implant stability, we compared the radiographs obtained 3 weeks postoperatively with those obtained at each subsequent measurement point. Periprosthetic osteolysis was defined as new cystic lucency (>2 mm in thickness) localized on the endosteal surface of the bone. 22 Migration of the femoral component was defined as a change of !3 mm in the position of the implant. 22 To assess the stability of the acetabular component, we modified the method described by Engh et al. The acetabular component was defined as stable, suboptimally stable (migrated 2 mm or tilted 5˚), or unstable (migrated >2 mm or tilted >5˚).
Analysis of Femoral Head Penetration
Three independent reviewers measured the position of the femoral head on digitized radiographic images obtained at 3 weeks, 6 months, 1, 3, and 5 years subsequent to index surgery, without consulting clinical information. They employed a computerized method featuring a digital edgedetection algorithm to fit circles and ellipses (PolyWare technique; Draftware Inc., Vevay, IN). 44 This technique relies on computer-assisted technology to create a threedimensional solid model of the acetabular component and femoral head, based on back-projection of the radiographs, femoral head size, and knowledge of the design of the acetabular component (computer-aided design library of various prosthetic brands in the software). 45 Each reviewer measured the position of the femoral head on a radiograph three times and recorded the median as the measured value. We calculated the average value of these three measured values and stored this information in a database as observed data. We then calculated the change in the femoral head position for each patient to reflect the extent of femoral head penetration, using the position at 3 weeks as the original position. To evaluate HXLPE liner wear, we classified the progression of femoral head penetration into two phases, as previously reported: A "bedding-in" phase and a "steady-state wear" phase. [7] [8] [9] [10] 12, 13 In the bedding-in phase, the femoral head moves rapidly into the liner; this is largely attributed to permanent plastic deformation of the material and intrusion of the liner into the metal shell. 7 In the steady-state wear phase, the femoral head moves into the liner slowly; this is attributed mainly to true wear-material loss in the form of particles-and considered the steady-state wear rate. We used these terms to describe the measurement results.
Statistical Methods
A paired t-test was performed to compare JOA scores, Harris Hip Scores, and normalized SF-36 scores recorded prior to the operation and 5 years postoperatively. A Student t-test was performed to examine the correlations between the dislocation and alignment of the acetabular component, and the measurement of femoral head penetration and patient-related (e.g., sex, age, and body mass index [BMI]) or surgical (e.g., femoral head size, PE liner thickness, and alignment of the acetabular component) factors.
RESULTS
Clinical Evaluation
The mean JOA score had increased significantly, from 43 AE 10 (mean AE standard deviation) to 94 AE 6 five years postoperatively (p < 0.01; Table 2 ); in addition, pain, range of motion (ROM), gait, and activities of daily living (ADL), improved significantly for all parameters (p < 0.01; Table 2 ). In particular, there was a marked improvement in pain scores, which rose from 12 AE 6 to 39 AE 2. Both mean flexion and abduction range had improved significantly 5 years postoperatively (p < 0.01; Table 3 ). According to Fujisawa's regression formula, 39 mean JOA scores prior to THR and 5 years postoperatively corresponded to Harris Hip Scores of 39 AE 8 and 97 AE 6 (p < 0.01), respectively.
Prior to 5-year follow up, 1 patient (1 hip) died of a cause unrelated to the joint replacement, and 11 patients (11 hips) were lost or refused to return for follow up. Therefore, 68 patients (85%; 68 hips) underwent 5-year follow up with complete clinical and radiographic evaluations. Preoperative demographic data are summarized in Table 4 .
No adverse events attributed to the implanted PMPC-grafted HXLPE liner were recorded, and no revision surgery was performed during the follow-up period. Two patients (Cases 15 and 16) experienced deep vein thrombosis without associated pulmonary embolism and were treated successfully with anticoagulants, and two (Cases 11 and 79) experienced posterior dislocation, which was treated via manual reduction. No deep infection occurred.
Assessment of Quality of Life
Of 68 patients, 1 (Case 36) refused to participate and 1 (Case 54) returned an incomplete questionnaire. In addition, we could not assess social function scores preoperatively because of misprints concerning social function in the questionnaire. Therefore, we assessed the seven remaining items in 66 patients (66 hips). All seven scaled scores showed significant improvements 5 years postoperatively (p < 0.01; Fig. 1 ). Mean PCS, MCS, and RCS scores were 46 AE 11, 57 AE 9, and 48 AE 9, respectively, 5 years postoperatively. The mean social function score was 51 AE 9 five years postoperatively. 46 Two patients (Cases 11 and 79) experienced posterior dislocation, and one patient (Case 79) was implanted in the Lewinnek safe zone.
Neither periprosthetic osteolysis nor femoral component migration was detected in the radiographic evaluation (Fig. 2) . Stable acetabular components were observed in 66 patients, with suboptimally stable components observed in two patients (Cases 33, 36). In the patients with suboptimally stable acetabular components, the component had changed position up to 6 months subsequent to the index surgery and stabilized thereafter. We attributed this limited migration to insufficient initial component seating.
9,47
Femoral Head Penetration Rate Mean bedding-in penetration (penetration during the first year) was 0.225 AE 0.107 mm (Fig. 3) and correlated with the inclination of the acetabular component (Table 5 ). However, bedding in was not correlated with sex, age, BMI, preoperative diagnosis, Charnley category, liner thickness, or anteversion of the acetabular component. Between 1 and 5 years postoperatively, the mean steady-state wear rate was 0.002 AE 0.023 mm/year. PMPC-grafted HXLPE liners showed similar steady-state wear rates at intervals of 1-3 (0.001 AE 0.041 mm/year), and 3-5 years (0.002 AE 0.043 mm/year). The mean steady-state wear rate was not significantly affected by sex, age, BMI, preoperative diagnosis, Charnley category, liner thickness, or component position (Table 6 ).
DISCUSSION
In the present study, we evaluated clinical and radiographic outcomes for PMPC-grafted HXLPE liners in primary THR 5 years postoperatively. The results provide preliminary evidence of clinical safety and wear resistance for PMPC-grafted HXLPE liners, which suggests that this biomimetic nanotechnology could be a promising approach to extending the longevity of artificial hip joints. The main difference between other medical devices using MPC polymers and the PMPC-grafted HXLPE liner is the chemical compound ratio of MPC polymer used for surface treatment; other devices use copolymers (e.g., MPC content of 30%), and the PMPC-grafted HXLPE uses a homopolymer (i.e., MPC content of 100%). Moreover, the surface of the PMPC-grafted HXLPE liner was modified using a photoinduced graft polymerization technique, which is considered appropriate for withstanding weight. 26 Therefore, we studied the influence of PMPC-grafted HXLPE liners on the health of users to verify safety and functionality. In the present study, THR using this liner provided good clinical results, and no adverse events associated with the liner had occurred during the 5 years subsequent to surgery. 
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Therefore, it should be considered a safe option in hip replacement. Bedding-in penetration was 0.225 AE 0.107 mm, which is similar to that of other HXLPE liners. [8] [9] [10] As the technique used in photoinduced graft polymerization of MPC involves nanometer-scaled surface modification, it does not affect the physical or mechanical properties of the HXLPE substrate. 30 Clinically, these findings are important. Although PMPC grafting was maintained for 70 million loading cycles in hip simulator tests, which is comparable to 70 years' use of a hip prosthesis in a typical patient, 33 these studies do not account for unexpected or accidental situations such as potential third-body abrasive damage to the femoral head, which is widely believed to be caused by thirdbody wear from particles of bone, cement, or metal components. 48 There is some concern regarding how well the PMPC-grafted HXLPE liner resists abrasion by a femoral head that has been damaged by thirdbody abrasion in vivo. However, the findings obtained in our previous studies clearly indicated that if the PMPC-grafted layer was removed in unexpected or accidental situations, the HXLPE substrate served as the new bearing surface in a similar manner to those of other HXLPE liners. 30, 49 With respect to PMPC-grafted HXLPE liners' clinical wear performance, the mean steady-state wear rate was 0.002 AE 0.023 mm/year. According to a systematic review conducted by Kurtz et al., steady-state wear rates for conventional PE and first-generation HXLPE were 0.137 (28 studies, 1,503 hips) and 0.042 mm/year (18 studies, 695 hips), respectively. 11 Of the studies included in this review, six used similar bearing couples, consisting of a 26-or 28-mm-diameter Co-Cr-Mo alloy femoral head and an HXLPE liner secured in a cementless shell, and reported steadystate wear rates that varied between 0.01 and 0.06 mm/year. [7] [8] [9] [10] 12, 13, 22 Further, recent studies used similar bearing couples, reporting steady-state wear rates that varied between 0.02 and 0.05 mm/year (Table 7) . 15, 36, [50] [51] [52] Moreover, using recent sequentially irradiated and annealed (second-generation) HXLPE, D'Antonio et al. reported a mean steady-state wear rate of 0.015 mm/year 5 years postoperatively. Although PE wear is a multifactorial process, 53 the results of the present study compare favorably with those of the other studies; that is, they show a marked reduction in wear. PE wear behavior in the artificial hip joint is known to be determined by an interplay of multiple influences including patient-related (e.g., sex, age, and BMI) and surgical factors (e.g., femoral head size, PE liner thickness, and acetabular component position). 54 However, the mean steady-state wear rate was not correlated with patient age, BMI, sex, Charnley category, preoperative diagnosis, liner thickness, or component position (inclination and anteversion of the acetabular component) in the present study. The lower steady-state wear rate may have reduced the influence of these factors, and longer follow up could yield greater differences in steady-state wear rates.
The study was subject to several limitations. The first concerns the size and design of the cohort; 68 individuals and 5-year follow up may have been insufficient to exclude the possibility of rare adverse reactions related to the new bearing, including periprosthetic osteolysis, particularly when evaluating very low wear. Therefore, a long-term follow-up study involving this cohort (UMIN000003681) is underway to perform an extended investigation. In addition, only one femoral head size (26 mm) and one type of femoral head (Co-Cr-Mo alloy) were used in the present study. Clinically, ceramic and larger femoral heads are available for use with HXLPE liners. In particular, larger femoral heads have recently been used more frequently to prevent THA dislocation. 17 However, there are concerns regarding subsequent use of thinner PE liners and their effects on increased volumetric wear rates and liner fracture. 17, 18 Although we previously confirmed marked wear resistance for PMPCgrafted liners against ceramic or larger femoral heads (40 mm) in hip joint simulator studies, 31, 34 outcomes for THR using other femoral heads should be evaluated to determine the clinical utility of PMPC-grafted HXLPE liners. Therefore, a large multicenter study (760 hips in 19 institutions: UMIN000008730) has been underway since 2012 to evaluate PMPC-grafted liners (Aquala 1 ; KYOCERA Medical Corp.) against various femoral heads, including zirconia-toughened alumina ceramic femoral heads and those with larger diameters. 55 Moreover, the cohort in the present study was not randomized. Most candidates preferred the new liner because of its potential benefits and did not want to join a clinical trial in which the liner was chosen by chance. 22 Therefore, we conducted a prospective cohort study to address this issue.
Second, to evaluate the extent of wear, we used the PolyWare technique rather than the radiostereometric analysis (RSA) method, which has been reported to be the most accurate tool for in vivo assessment of PE wear. 56 Hui et al. reported that the measurement of wear using plain radiographs showed limited sensitivity, particularly when monitoring very low wear. 44 However, many potential candidates believe that metal marker balls, required for the RSA method, are of no benefit. In addition, Stilling et al. reported that the mean extent of wear tends to be greater when measured using PolyWare relative to that measured via the RSA method. 57 Notably though, the wear values in this study, which were determined using the PolyWare method, included a certain amount of radiographic measurement errors. Therefore, the extent of wear may have been overestimated in the present study. That might be evidenced by the previous studies that demonstrated large measurement errors, as indicated by other authors. However, we think that no clear consensus exists regarding the treatment of this potential problem. Future accurate and precise investigations using this measurement tool are expected.
Third, we could not assess social function scores preoperatively because of misprints in the questionnaire items concerning social function. However, the social function value, normalized via the reference score for the general population aged over 45 years, was 51 AE 9 five years postoperatively. This score was similar to those of other studies involving SF-36 evaluation subsequent to THR. 41 In conclusion, our clinical experience with PMPCgrafted HXLPE liners has clearly shown safety and marked reduction in wear 5 years subsequent to surgery. No adverse events were attributed to the implanted PMPC-grafted HXLPE liner, and osteolysis was not detected during the follow-up period. Although studies involving longer follow-up periods are required to elucidate the true clinical benefit of PMPC-grafted HXLPE liners in THR, the results of the present study suggest that they will improve the longevity of artificial hip joints.
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